Silence Therapeutics to Participate in Fireside Chat at Piper Sandler 36th Annual Healthcare Conference
Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today announced the Company will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4th at 10:00 a.m. ET.
The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.
About Silence Therapeutics
Silence Therapeutics is a global clinical stage biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines created with proprietary siRNA (short interfering RNA) technology. Silence leverages its mRNAi GOLDtm platform to create innovative siRNAs designed to precisely target and silence disease associated genes in the liver, which represents a substantial opportunity. Silence focuses on areas of high unmet medical need with programs advancing in cardiovascular disease, hematology and rare diseases. Silence also maintains research and development collaborations with AstraZeneca and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.
Today Mediplanet launches their Women in Research campaign, aimed at addressing gender disparities in the U.S. research workforce. Making up 30% of the research workforce, women continue to face systemic challenges, including gender bias, lack of...
Product: Dips
Issue: Food - Allergen ? Peanut
Distribution: AlbertaBritish ColumbiaPossibly other provinces and territories
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
-The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing treatments-The BTD designation, achieved following...
Investing in Canadians' health is key to building a stronger Canada. In its first year, the Canadian Dental Care Plan (CDCP) has significantly improved access to affordable dental care. More than 3.4 million Canadians were approved to be part of the...
Product: Organic Almond Butter Cup
Issue: Food - Allergen ? Peanut
Distribution: National Online
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The official brand behind Prime Biome has issued a public advisory regarding unauthorized third-party resellers misrepresenting the product online. Reports of unverified vendors listing non-official versions of Prime Biome across various platforms...